A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing hydrogel-based platform designed to overcome one of the biggest hurdles in conventional mRNA cancer vaccines: the extremely low efficiency of antigen-encoded mRNAs being processed by the right type of immune cells in the body.
Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines
